CRTX Cortexyme, Inc.

Develops novel treatment for altering the course of neurodegenerative diseases

$12.45  -0.59 (-4.53%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/27/2004
Outstanding shares:  29,877,608
Average volume:  1,852,140
Market cap:   $389,604,008
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    22053A107
ISIN:        US22053A1079
Sedol:      BJL3925
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.80
PS ratio:   0.00
Return on equity:   -65.66%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy